Insights

Expanding Market Reach Enalees' recent partnership with Unisensor SA and its expansion into the DACH region demonstrate significant growth in veterinary diagnostics across Europe, offering opportunities to collaborate with distributors and regional partners to further penetrate local markets.

Innovative Product Portfolio The launch of new rapid molecular diagnostic solutions like Rhéa for cattle, sheep, and goats, along with specialized tests such as the feline coronavirus kit, presents avenues to upsell and bundle tailored diagnostic packages to veterinary clinics and animal health providers.

Increased Production Capacity With a focus on relocating manufacturing to France and significantly enhancing production capabilities, Enalees is well-positioned to meet rising demand, enabling sales teams to promote large-volume contracts and scalable service offerings to large veterinary labs and animal health companies.

Technological Leadership Enalees’ expertise in PCR technology using LAMP and its continual product innovation, including the updated molecular biology analyzer showcased at veterinary events, presents opportunities to position Enalees as a technology leader and secure strategic partnerships with research institutions and biotech firms.

Financial Growth Potential Having secured $16M in funding with a revenue range of up to $10M, Enalees is in a growth phase, making it a compelling partner for investors or collaborators seeking to scale innovative veterinary diagnostic solutions across Europe and beyond.

Enalees Tech Stack

Enalees uses 8 technology products and services including Google PageSpeed, WooCommerce, Google Fonts API, and more. Explore Enalees's tech stack below.

  • Google PageSpeed
    Caching
  • WooCommerce
    E-commerce
  • Google Fonts API
    Font Scripts
  • Slick
    Javascript Libraries
  • imagesLoaded
    Javascript Libraries
  • Quantcast
    System Analytics & Monitoring
  • Bootstrap
    UI Frameworks
  • Polylang
    Web Platform Extensions

Media & News

Enalees's Email Address Formats

Enalees uses at least 1 format(s):
Enalees Email FormatsExamplePercentage
First.Last@enalees.comJohn.Doe@enalees.com
100%

Frequently Asked Questions

Where is Enalees's headquarters located?

Minus sign iconPlus sign icon
Enalees's main headquarters is located at 5 Rue Henri Desbruères Évry, Île-de-france France. The company has employees across 3 continents, including EuropeAfricaNorth America.

What is Enalees's official website and social media links?

Minus sign iconPlus sign icon
Enalees's official website is enalees.com and has social profiles on LinkedInCrunchbase.

What is Enalees's SIC code NAICS code?

Minus sign iconPlus sign icon
Enalees's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enalees have currently?

Minus sign iconPlus sign icon
As of April 2026, Enalees has approximately 42 employees across 3 continents, including EuropeAfricaNorth America. Key team members include Founder And Ceo: L. T.Marketing & Communication Director: F. F.General Manager: L. C.. Explore Enalees's employee directory with LeadIQ.

What industry does Enalees belong to?

Minus sign iconPlus sign icon
Enalees operates in the Biotechnology Research industry.

What technology does Enalees use?

Minus sign iconPlus sign icon
Enalees's tech stack includes Google PageSpeedWooCommerceGoogle Fonts APISlickimagesLoadedQuantcastBootstrapPolylang.

What is Enalees's email format?

Minus sign iconPlus sign icon
Enalees's email format typically follows the pattern of First.Last@enalees.com. Find more Enalees email formats with LeadIQ.

How much funding has Enalees raised to date?

Minus sign iconPlus sign icon
As of April 2026, Enalees has raised $16M in funding. The last funding round occurred on Jul 27, 2024 for $16M.

When was Enalees founded?

Minus sign iconPlus sign icon
Enalees was founded in 2016.

Enalees

Biotechnology ResearchÎle-de-france, France11-50 Employees

Enalees is a biotech specialized in the development and marketing of lyophilized molecular diagnostic tests for animal healthcare in Europe. 

Leader of PCR type veterinary tests, Enalees uses the technology named LAMP (Loop-mediated isothermal amplification) to diagnose infectious canine, feline, and equine diseases in a simple, rapid, and reliable fashion. 
Thanks to its expertise in lyophilization, Enalees also provides development opportunities for other companies in the health, agriculture, and environment sector. 

Relocating the creation and production of rapid molecular diagnostic tests in France has also become an ambition of the company. Enalees already demonstrated the proof of concept by developing a Covid-19 screening test with several French companies thanks to its technical expertise in rapid molecular diagnosis. Its production capacity has augmented significantly, offering the possibility of assay development and product lyophilization for partners.

Section iconCompany Overview

Headquarters
5 Rue Henri Desbruères Évry, Île-de-france France
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $16M

    Enalees has raised a total of $16M of funding over 2 rounds. Their latest funding round was raised on Jul 27, 2024 in the amount of $16M.

  • $1M$10M

    Enalees's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $16M

    Enalees has raised a total of $16M of funding over 2 rounds. Their latest funding round was raised on Jul 27, 2024 in the amount of $16M.

  • $1M$10M

    Enalees's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.